DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
Clinical trial NCT06075953 · RECRUITING
Trial details
- NCT number
- NCT06075953
- Sponsor
- QuantumLeap Healthcare Collaborative
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-17
- Primary completion
- 2028-11-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.